PROPORTIONAL ELECTROMYOGRAPHIC CONTROL OF A BIONIC ARM IN A PARTICIPANT WITH CHRONIC HEMIPARESIS, MUSCLE SPASTICITY,
Caleb J Thomson1, Jacob A George1,2,3,4
1Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Summary
This study shows that advanced electromyographic (EMG) control can enable proportional movement in a bionic arm for stroke survivors with hemiparesis, even with weak muscle signals. This offers hope for improved assistive device control.
Area of Science:
- Biomedical Engineering
- Neurorehabilitation
- Robotics
Background:
- Stroke is a leading cause of disability, often resulting in hemiparesis.
- Current assistive exoskeletons lack fine motor control, offering only binary (on/off) functionality.
- Electromyographic (EMG) signals are crucial for controlling prosthetic and robotic devices.
Purpose of the Study:
- To investigate the feasibility of proportional EMG control for a bionic arm in a stroke patient with hemiparesis.
- To assess the performance of state-of-the-art EMG control algorithms with weak and spastic muscle activity.
- To compare control using paretic versus healthy arm EMG signals.
Main Methods:
- A case study involving one hemiparetic stroke patient using an EMG-controlled bionic arm.
- The participant performed a virtual target-touching task, grasping and extending.
- EMG data was collected from both the paretic and healthy arms for comparison.
Main Results:
- Proportional control was achieved for grasping with the paretic arm, despite reduced EMG signal-to-noise ratio.
- Extension task performance and EMG signal-to-noise ratio significantly decreased for the paretic arm.
- The participant successfully completed the task using EMG from the paretic arm, indicating potential for functional control.
Conclusions:
- State-of-the-art EMG control can provide proportional force regulation for assistive devices in some stroke patients with hemiparesis.
- Functional motor control information remains present in EMG signals despite hemiparesis.
- Further research with diverse patient populations is needed to validate and advance upper-limb exoskeleton control.


